Report Detail
Global Donepezil Market Insights, Forecast to 2025
- RnM3362281 |
- 29 April, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Donepezil is a medication used in the palliative treatment of Alzheimer's disease. Donepezil is used to improve cognition and behavior of people with Alzheimer's, but does not slow the progression of or cure the disease.
Common side effects include loss of appetite, gastrointestinal upset, diarrhea, difficulty sleeping, vomiting, or muscle cramping.
The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.
North America is the largest consumption region of Donepezil, with a sales market share nearly 37% in 2017. Europe is the second largest consumption region of Donepezil, enjoying Sales market share nearly 29% in 2017.
Donepezil was developed by Eisai and Pfizer and is sold as a generic by multiple suppliers. Donepezil acts as a centrally acting reversible acetylcholinesterase inhibitor.
The global Donepezil market is valued at 920 million US$ in 2018 and will reach 880 million US$ by the end of 2025, growing at a CAGR of -0.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Donepezil market based on company, product type, end user and key regions.
This report studies the global market size of Donepezil in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Donepezil in these regions.
This research report categorizes the global Donepezil market by top players/brands, region, type and end user. This report also studies the global Donepezil market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin
Market size by Product
5mg
10mg
23mg
Market size by End User
Hospitals
Clinics
Drugstore
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Donepezil market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Donepezil market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Donepezil companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Donepezil submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Donepezil are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Donepezil market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Donepezil Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Donepezil Market Size Growth Rate by Product
- 1.4.2 5mg
- 1.4.3 10mg
- 1.4.4 23mg
- 1.5 Market by End User
- 1.5.1 Global Donepezil Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Drugstore
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Donepezil Market Size
- 2.1.1 Global Donepezil Revenue 2014-2025
- 2.1.2 Global Donepezil Sales 2014-2025
- 2.2 Donepezil Growth Rate by Regions
- 2.2.1 Global Donepezil Sales by Regions
- 2.2.2 Global Donepezil Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Donepezil Sales by Manufacturers
- 3.1.1 Donepezil Sales by Manufacturers
- 3.1.2 Donepezil Sales Market Share by Manufacturers
- 3.1.3 Global Donepezil Market Concentration Ratio (CR5 and HHI)
- 3.2 Donepezil Revenue by Manufacturers
- 3.2.1 Donepezil Revenue by Manufacturers (2014-2019)
- 3.2.2 Donepezil Revenue Share by Manufacturers (2014-2019)
- 3.3 Donepezil Price by Manufacturers
- 3.4 Donepezil Manufacturing Base Distribution, Product Types
- 3.4.1 Donepezil Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Donepezil Product Type
- 3.4.3 Date of International Manufacturers Enter into Donepezil Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Donepezil Sales by Product
- 4.2 Global Donepezil Revenue by Product
- 4.3 Donepezil Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Donepezil Breakdown Data by End User
6 North America
- 6.1 North America Donepezil by Countries
- 6.1.1 North America Donepezil Sales by Countries
- 6.1.2 North America Donepezil Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Donepezil by Product
- 6.3 North America Donepezil by End User
7 Europe
- 7.1 Europe Donepezil by Countries
- 7.1.1 Europe Donepezil Sales by Countries
- 7.1.2 Europe Donepezil Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Donepezil by Product
- 7.3 Europe Donepezil by End User
8 Asia Pacific
- 8.1 Asia Pacific Donepezil by Countries
- 8.1.1 Asia Pacific Donepezil Sales by Countries
- 8.1.2 Asia Pacific Donepezil Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Donepezil by Product
- 8.3 Asia Pacific Donepezil by End User
9 Central & South America
- 9.1 Central & South America Donepezil by Countries
- 9.1.1 Central & South America Donepezil Sales by Countries
- 9.1.2 Central & South America Donepezil Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Donepezil by Product
- 9.3 Central & South America Donepezil by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Donepezil by Countries
- 10.1.1 Middle East and Africa Donepezil Sales by Countries
- 10.1.2 Middle East and Africa Donepezil Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Donepezil by Product
- 10.3 Middle East and Africa Donepezil by End User
11 Company Profiles
- 11.1 Eisai
- 11.1.1 Eisai Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Eisai Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Eisai Donepezil Products Offered
- 11.1.5 Eisai Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Pfizer Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Pfizer Donepezil Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 Teva
- 11.3.1 Teva Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Teva Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Teva Donepezil Products Offered
- 11.3.5 Teva Recent Development
- 11.4 Sandoz
- 11.4.1 Sandoz Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sandoz Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sandoz Donepezil Products Offered
- 11.4.5 Sandoz Recent Development
- 11.5 Apotex
- 11.5.1 Apotex Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Apotex Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Apotex Donepezil Products Offered
- 11.5.5 Apotex Recent Development
- 11.6 Dr Reddy's Laboratories
- 11.6.1 Dr Reddy's Laboratories Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Dr Reddy's Laboratories Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Dr Reddy's Laboratories Donepezil Products Offered
- 11.6.5 Dr Reddy's Laboratories Recent Development
- 11.7 Sun Pharmaceutical
- 11.7.1 Sun Pharmaceutical Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Sun Pharmaceutical Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Sun Pharmaceutical Donepezil Products Offered
- 11.7.5 Sun Pharmaceutical Recent Development
- 11.8 Hansoh Pharma
- 11.8.1 Hansoh Pharma Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Hansoh Pharma Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Hansoh Pharma Donepezil Products Offered
- 11.8.5 Hansoh Pharma Recent Development
- 11.9 Cipla
- 11.9.1 Cipla Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Cipla Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Cipla Donepezil Products Offered
- 11.9.5 Cipla Recent Development
- 11.10 ARK PHA.LTD
- 11.10.1 ARK PHA.LTD Company Details
- 11.10.2 Company Business Overview
- 11.10.3 ARK PHA.LTD Donepezil Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 ARK PHA.LTD Donepezil Products Offered
- 11.10.5 ARK PHA.LTD Recent Development
- 11.11 Jishengtang Pharma
- 11.12 Luoxin
12 Future Forecast
- 12.1 Donepezil Market Forecast by Regions
- 12.1.1 Global Donepezil Sales Forecast by Regions 2019-2025
- 12.1.2 Global Donepezil Revenue Forecast by Regions 2019-2025
- 12.2 Donepezil Market Forecast by Product
- 12.2.1 Global Donepezil Sales Forecast by Product 2019-2025
- 12.2.2 Global Donepezil Revenue Forecast by Product 2019-2025
- 12.3 Donepezil Market Forecast by End User
- 12.4 North America Donepezil Forecast
- 12.5 Europe Donepezil Forecast
- 12.6 Asia Pacific Donepezil Forecast
- 12.7 Central & South America Donepezil Forecast
- 12.8 Middle East and Africa Donepezil Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Donepezil Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Donepezil . Industry analysis & Market Report on Donepezil is a syndicated market report, published as Global Donepezil Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Donepezil market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
